FIA
WST icon

FNY Investment Advisers’s West Pharmaceutical WST Stock Holding History

FNY Investment Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-150
Closed -$21K – 1097
2019
Q3 		$21K Buy
+150
New +$20.7K 0.01% 510

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

FNY Investment Advisers's WST Position: Q4 2019 in Review

FNY Investment Advisers sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 150 shares — an estimated $21K sold.

FNY Investment Advisers first reported a position in WST in Q3 2019 and held it in 1 quarter. The position peaked at $21K in Q3 2019. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • FNY Investment Advisers reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • FNY Investment Advisers sold 150 West Pharmaceutical shares in Q4 2019, an estimated $21K.
  • FNY Investment Advisers first reported a position in West Pharmaceutical in Q3 2019 and held it in 1 quarter.
  • FNY Investment Advisers's West Pharmaceutical position peaked at $21K in Q3 2019.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.